About Evaluate
Evaluate is a Healthcare company based in London (United Kingdom) founded in 1996, and was acquired by HgCapital Trust in August 2020. Pharmaceutical market intelligence and forecasting solutions are provided by Evaluate. It operates on a Data-as-a-Service and Professional Services model. Evaluate has completed 5 acquisitions, including BiosciDB, Bioscience Advisors and Black Swan Analysis. Its website evaluate.com draws about 75 thousand monthly visits. Evaluate offers products and services including Evaluate Pharma, Evaluate Omnium, and Pharma Forecasting Platform. Its focus areas include Biotechnology & Pharmaceuticals and Pharmaceutical Services. Its legal entity is Evaluate, a Norstella Company. Its competitors include J+D Forecasting and Branding Science.
Company details
Evaluate is engaged in delivering comprehensive pharmaceutical market intelligence and forecasting solutions. Services are focused on supporting biotech and pharma companies with data-driven insights for drug development, market competition, and portfolio optimization. Sectors covered include biopharma and medtech, with solutions encompassing competitive intelligence, business development, licensing, and custom analytics. A wide range of tools and consulting services are offered to help clients navigate market complexities and make informed strategic decisions.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website evaluate.com
- Social LinkedIn X Instagram
- Acquired by HgCapital Trust (Aug 2020)
- Legal Name Evaluate, A Norstella Company
- Annual Revenue$89.89 K (USD)-2as on Dec 31, 2022
- Net Profit$16.54 K (USD)-25as on Dec 31, 2022
- Investors
- Investments & AcquisitionsBiosciDB
& 4 more
- Acquired byHgCapital Trust
(Aug 2020)
Products & Services of Evaluate
Evaluate offers a comprehensive portfolio of products and services, including Evaluate Pharma, Evaluate Omnium, and Pharma Forecasting Platform.
Data and insights for pharmaceutical market analysis are provided.
Comprehensive market data for drug development is offered here.
Tools for market sizing and forecasting are made available.
Funding Insights of Evaluate
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Evaluate with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2016 | Private Equity Round | – | HgCapital Trust | – |
1 investors in total: 1 institutional.
Investors in Evaluate
Evaluate has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include HgT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are focused on European software firms. | 1980 | hgcapitaltrust.com | London, United Kingdom |
Investor details for Evaluate
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Evaluate
10 people are tracked at Evaluate (6 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Cem Baydar | Chief Consulting Officer | Leadership |
Michael Hay | Strategic Intelligence General Manager | Leadership |
Stephanie Cooper Johnson | Director Of Product Marketing | Leadership |
Chris Kelley | Chief Revenue Officer | Leadership |
Paul Verdin | Vp, Head Of Consulting & Analytics | Leadership |
Andrew Davis | New Business Development, Senior Director At Evaluate Pharma - A Norstella Company | Leadership |
Christina Kay | SVP, Customer Success | Team |
Louise Challoner | Senior Retention And Account Based Marketing Manager | Team |
Natasha Choukkar | Senior Manager, Consulting (asset/portfolio Advisory Strategy) | Team |
Ian Strickland | Senior Commercial Analyst | Team |
Complete people profiles for Evaluate
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evaluate
Evaluate has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include BiosciDB, Bioscience Advisors and Black Swan Analysis.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical forecasting services are provided for global and local markets. | jdforecasting.com | Cheadle Hulme, United Kingdom | 2005 | Jan 2024 | •••• | |
Provider of healthcare analytics software for clinics | panalgo.com | Boston, United States | 1996 | Sep 2021 | •••• | |
Cloud-based database management software is offered for healthcare professionals. | bioscidb.com | Walnut Creek, United States | 2012 | May 2021 | •••• | |
Consulting services for the biopharma sector are provided. | biosciadvisors.com | Walnut Creek, United States | 2011 | May 2021 | •••• | |
Provider of market analysis & access, data analytics, and consulting services for pharmaceutical sector | blackswan-analysis.co.uk | Maidenhead, United Kingdom | 2007 | Mar 2020 | •••• |
Complete acquisition details for Evaluate
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Evaluate
8 dated milestones of Evaluate across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Evaluate is founded.
- Funding First funding round.
- Acquisition Acquires Black Swan Analysis.
- Exit Acquired by HgCapital Trust.
- Acquisition Acquires BiosciDB.
- Acquisition Acquires Bioscience Advisors.
- Acquisition Acquires Panalgo.
- Acquisition Acquires J+D Forecasting.
Competitors of Evaluate
Evaluate has 2 listed competitors in our database. They include J+D Forecasting and Branding Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| jdforecasting.com | 2005 | Cheadle Hulme, United Kingdom | Pharmaceutical forecasting services are provided for global and local markets. | |||
| branding-science.com | 2002 | London, United Kingdom | 29 | Global consultancy providing behavioral insights and strategies for pharma brands. |
Detailed competitors of Evaluate
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Evaluate
The website of Evaluate (evaluate.com) receives about 75.4K visits a month and ranks #573,152 among all websites worldwide, #601 in Biotechnology and Pharmaceuticals.
- Monthly visits75.4K
▲ 44.7% vs previous month
- Unique visitors23.1K
per month
- Global rank#573,152
among all websites
- Category rank#601
Health · Biotechnology and Pharmaceuticals
- Bounce rate49%
- Pages per visit2.7
- Average visit1 min 12 sec
- DevicesDesktop 46% · Mobile 54%
Websites whose visitors overlap most with Evaluate. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cliniminds.com | cliniminds.com | 100% | #1,196,899 | – | |
| cphi-online.com | 98% | #227,074 | View details | ||
evaluategroup.com | evaluategroup.com | 98% | #14,639,274 | – | |
| ppd.com | 97% | 226.8K | #271,623 | View details | |
| citeline.com | 95% | 127.1K | #291,889 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 33 similar websites and full traffic analytics for Evaluate
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 33 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Evaluate
Complete news archive for Evaluate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evaluate
Evaluate was founded in 1996 and raised its 1st funding round 20 years after it was founded.
Evaluate is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Annual revenue of Evaluate is $89.89K as on Dec 31, 2022.
Evaluate is engaged in delivering comprehensive pharmaceutical market intelligence and forecasting solutions. Services are focused on supporting biotech and pharma companies with data-driven insights for drug development, market competition, and portfolio optimization. Sectors covered include biopharma and medtech, with solutions encompassing competitive intelligence, business development, licensing, and custom analytics. A wide range of tools and consulting services are offered to help clients navigate market complexities and make informed strategic decisions.
Evaluate's top competitors include J+D Forecasting and Branding Science.
Evaluate offers Evaluate Pharma, Evaluate Omnium, and Pharma Forecasting Platform.
Evaluate has made 5 acquisitions, including BiosciDB, Bioscience Advisors, and Black Swan Analysis.
Evaluate has 1 investor. Key investors include HgT.
Evaluate operates through Evaluate, A Norstella Company.
Yes. Evaluate was acquired by HgCapital Trust in August 2020.